|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
The production of water for injection (WFI) is a critical process operation for any pharmaceutical manufacturing facility requiring this quality of water. The processes used are to ensure the water is treated correctly and all contaminants are stripped out, leaving WFI quality water.
WFI is produced predominantly via distillation; this is a requirement of the European Pharmacopoeia. Other such pharmacopoeias, like United States Pharmacopeia (USP) and Japanese Pharmacopoeia (JP), allow the use of membrane technology through reverse osmosis and ultrafiltration to attain WFI quality water.
The production of WFI by membrane technology is not thought to be as effective as distillation due to inherent risks of membrane processes, their ease of bacterial and chemical contamination and loss of integrity. The water is also processed at ambient temperatures, as opposed to those elevated temperatures witnessed during distillation.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
FT Global Pharmaceutical and Biotechnology Conference 2008
2-3 December 2008, The Cumberland, London
FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >> |
|
 |
News and Press Releases |
 |
Lilly Selects ICON to Manage its Clinical Data Management Business Outside the US
18th November 2008
More info >> |
|
|
